IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,221 | -23.1% | 71 | -30.4% | 0.00% | 0.0% |
| Q2 2023 | $4,186 | +14.8% | 102 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,646 | -5.4% | 102 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,853 | -22.9% | 102 | -10.5% | 0.00% | -50.0% |
| Q3 2022 | $5,000 | +25.0% | 114 | +11.8% | 0.00% | +100.0% |
| Q2 2022 | $4,000 | +33.3% | 102 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | – | 102 | +920.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |